Cobra Biologics on Tuesday said it had signed a supply agreement with AstraZeneca (AZN.L) to manufacture its COVID-19 vaccine candidate, with a view to a first delivery of the potential vaccine to Britain in September.

Cobra is one of the firms that has been working to manufacture the vaccine, which was initially being developed by scientists at the University of Oxford. Source: Reuters 16/6/2020